X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

BY-HEALTH The Nutrition Exploratorium Launched in China

Content Team by Content Team
12th August 2019
in Health & Nutrition, Press Statements
BY-HEALTH Nutrition Exploratorium

BY-HEALTH Nutrition Exploratorium held its opening ceremony in Zhuhai Sanzao District. Many industry experts including Nobel laureate in Physics, Kip Thorne, attended and shared their understanding and expectation for the future of personalized health management plan.

The BY-HEALTH Nutrition Exploratorium, built at the cost of 100 million yuan, is nutrition-themed mixed-use for education and recreation. Overlooking from the air, the Exploratorium is a “Mobius ring,” the idea comes from “Mobius strip,” meaning the spirit of infinite exploration. Using cutting-edge technology and high-end immersion demonstration design, the Exploratorium brings advanced nutritional knowledge and high-end physical examination to the audience.

The BY-HEALTH Nutrition Exploratorium is consisting of the “Foreseeing 2050”, the Cloud Health Center , the Children World, Art Space and so on. In these areas, visitors can gain nutritional knowledge from the relaxing game experience.

For example, the “Foreseeing 2050”, through the immersive science interactive experience, shows the details of sleep, diet, psychology, physical fitness, etc.

The Cloud Health Center has big data processing systems, high-end health testing equipment, and professional dietitians, which create a new experience of health management. Visitors can enjoy eight testing services, including genetic testing, mental stress analysis, and chronic disease risk assessment.

According to BCG, Chinese customers are at the top of the world rank to purchase nutrition products. As an industry leader, founded in 1995,BY-HEALTH invested 100 million RMB to build Nutrition Exploratorium to provide new health services to Chinese customers.

BY-HEALTH first introduced dietary supplement system to China in 2002 and has adhered to a differentiated global quality strategy for a long time. It cooperates with a number of raw materials suppliers in 23 countries and regions to produce high-quality nutrition products.

In 2018, it acquired many overseas companies such as Life-Space, a well-known Australian probiotic brand, and Penta-vite, a children brand with a over 70-years history. BY-HEALTH also established a “collaborative innovation R&D cooperation platform” with the world’s leading research institutions and global raw materials suppliers, such as The Rowett Institute University of Aberdeen, BASF, The Netherlands Organization for Applied Scientific Research (TNO), Fonterra Co-operative Group, Indena (Italy), Royal DSM, and Bioberica S.A.U.

The BY-HEALTH Nutrition Exploratorium meets Chinese people’s demands for healthy life and demonstrates Chinese companies’ technological strength and innovation capabilities. The BY-HEALTH Nutrition Exploratorium also shows that Chinese health industry is changing from a general solution to personalized health services. In the future, BY-HEALTH will continue to lead the trend of customized health management, activate” health” curiosity of Chinese people, and start the journey of “nutrition” exploration.

Previous Post

Dynacure Receives Orphan Drug Designation from the US FDA for DYN101 an Antisense Medicine to Treat Rare Disease Centronuclear Myopathies

Next Post

Arcos Dorados Continues to Enhance Happy Meal by Offering More Nutritional Foods and Ingredients

Related Posts

ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Drug Development

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

4th March 2025
Health & Nutrition

Vitafoods India 2025 Ignites Powerful Knowledge Exchange, Elevating the Future of Nutraceuticals

7th February 2025
Next Post
Arcos Dorados Nutritional Foods and Ingredients

Arcos Dorados Continues to Enhance Happy Meal by Offering More Nutritional Foods and Ingredients

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In